Antibiotic prophylaxis for ERCP: A comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 3, 1998, Pages 207-211

  Davis, A J M ^a   Kolios, G ^a   Alveyn, C G ^b   Robertson, D A F ^a  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CIPROFLOXACIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BILE; BLOOD CULTURE; CHOLANGITIS; CLINICAL TRIAL; DIARRHEA; DRUG COST; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA; URTICARIA;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BILE; CEFAZOLIN; CEPHALOSPORINS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS; CIPROFLOXACIN; DIARRHEA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MICROBIAL SENSITIVITY TESTS; RISK FACTORS; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; TREATMENT OUTCOME; URTICARIA;

EID: 0031947801     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00291.x     Document Type: Article

References (25)

1. McCune WS, Shorb PE, Moscovitz H. Endoscopic cannulation of the Ampulla of Vater: a preliminary report. Ann Surg 1968; 167: 752-6.
2. Cotton PB. Duodenoscopic placement of biliary prosthesis to relieve malignant obstructive jaundice. Br J Surg 1974; 69: 501-5.
3. Classen M, Safrany L. Endoscopic papillotomy and removal of gallstones. Br Med J 1975; 4: 371-4.
4. Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases. Gastroenterology 1976; 70: 315-20.
5. Zimmon DS, Falkenstein DB, Riccobono C, Aaron B. Complications of endoscopic retrograde cholangiopancreatography. Gastroenterology 1975; 69: 303-9.
6. Mollison LC, Desmond PV, Stockman KA, et al. A prospective study of septic complications of endoscopic retrograde cholangiopancreatography. J Gastroenterol Hepatol 1994; 9: 55-9.
7. Niederau C, Pohlmann U, Lubke H, Thomas L. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gasrointest Endosc 1994; 40: 533-7.
8. Byl B, Deviere J, Struelens MJ, et al. Antibiotic prophylaxis for infectious complications after therapeutic retrograde cholangiopancreatography: A randomized, double-blind, placebo-controlled study. Clin Infect Dis 1995; 20: 1236-40.
9. Lam SK, Tsui JKC, Chan PKW, et al. How often does bacteraemia occur following endoscopic retrograde cholangiopancreatography (ERCP)? Endoscopy 1977; 9: 231-4.
10. Parker HW, Greenen JE, Bjork JT, Stewert ET. A prospective analysis of fever and bacteraemia following ERCP. Gastrointest Endosc 1989; 25: 102-3.
11. Kullman E, Borch K, Lindstrom E, et al. Bacteraemia following diagnostic and therapeutic ERCP. Gastrointest Endosc 1992; 38: 444-9.
12. Elson CO, Hattori K, Blackstone MO. Polymicrobial sepsis following endoscopic retrograde cholangiopancreatography. Gastroenterology 1975; 69: 507-10.
13. Cotton PB. Progress report - ERCP. Gut 1977; 18: 316-41.
14. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. New Engl J Med 1996; 335: 909-18.
15. Nebel OT, Silvis SE, Rogers G, et al. Complications associated with endoscopic retrograde cholangiopancreatography. Results of the 1974 ASGE survey. Gastrointest Endosc 1975; 22: 34-6.
16. Deviere J, Motte S, Dumonceau JM, et al. Septicaemia after endoscopic retrograde cholangiopancreatography. Endoscopy 1990; 22: 72-5.
17. Leung JWC, Ling TKW, Chan RCY, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc 1994; 40: 716-21.
18. Novello P, Hagege H, Ducreux M, et al. Septicaemias after endoscopic retrograde cholangiopancreatography. Risk factors and antibiotic prophylaxis. Gastroenterol Clin Biol 1993; 17: 897-902.
19. Sauter G, Grabein B, Huber G, et al. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy 1990; 22: 164-7.
20. Alveyn CG. Antimicrobial prophylaxis during biliary endoscopic procedures. J Antimicrob Chemother 1993; 31(Suppl. B): 101-5.
21. Siegman-Igra Y, Spinrad S, Rattan J. Septic complications following endoscopic retrograde cholangiopancreatography: the experience in Tel Aviv Medical Centre. J Hosp Infect 1988; 12: 7-12.
22. Davis R, Markham A, Balfour JA, Ciprofloxacin. An updated view of its pharmacology, therapeutic efficacy and tolerability. Drugs 1996; 51: 1019-74.
23. Alegente G, Savio S, De Lalla F. Biliary excretion of orally administered ciprofloxacin. Chemioterapia 1987; 6: 292-3.
24. Alveyn CG, Robertson DAF, Wright R, et al. Prevention of sepsis following endoscopic retrograde cholangiopancreatography. J Hosp Infect 1991; 19(Suppl. C): 65-70.
25. Wajahat Z, Culshaw KD, Tillotson GS, Chapman RW. Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis. Eur J Gastroenterol Hepatol 1995; 7: 841-5.